Kodiak Sciences Inc. (KOD) stock rallied over 1.44% intraday to trade at $7.75 a share on NASDAQ. The stock opened with a loss of -1.52% at $7.73 and touched an intraday high of $7.87, rising 1.44% against the last close of $7.64. The stock went to a low of $7.54 during the session.
Number of Shares
Cash Flow per Share
Free Float in %
Sales or Revenue0
5Y Sales Change-
Fiscal Year Ends2021-12-30
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as for the treatment of diabetic macular edema, naive macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet inhibitor for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.
Kodiak Sciences Inc. (NASDAQ: KOD) stock price is $7.75 as of the last check on Friday, July 1. During the trading session, KOD stock reached the peak price of $7.87 while $7.54 was the lowest point it dropped to.
The NASDAQ listed KOD is part of Biotechnology industry that operates in the broader Health Care sector. Kodiak Sciences Inc. , a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases.
Dr. Victor Perlroth M.D.
Co-Founder, Chairman, CEO & Pres
Mr. John A. Borgeson CPA, M.B.A., MBA, CPA
Sr. VP, CFO & Sec.
Dr. Jason S. Ehrlich M.D., Ph.D.
Chief Medical Officer & Chief Devel. Officer
Dr. Michael S. Louie Ph.D.
Sr. VP of Digital Transformation & Chief Information Officer
KOD stock traded closed the last session at $7.75, which is $0.11 or 1.44% lower than its previous close of $7.64. KOD's current trading price is 58.16% lower than its 52-week high of $131.97 where as its distance from 52-week low of 4.90% is -94.13%.
Number of KOD employees currently stands at -. KOD operates from 1200 Page Mill Road, Palo Alto, CA 94304, United States.
Official Webiste of $KOD is: https://kodiak.com
KOD stock volume for the day was 394,810 shares while in the previous session number of KOD shares traded was 394,800 . The average number of KOD shares traded daily for last 3 months was 967.51 Thousands.
The percentage change in KOD stock occurred in the recent session was 1.44% while the dollar amount for the price change in KOD stock was $0.11.
In the recent session, the day high for KOD stock was $7.87 while the low for KOD stock touched on the day was $7.54.
The market value of KOD currently stands at 396.88 Million with its latest stock price at $7.75 and 52.17 Million of its shares outstanding.